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Abstract 
Accurate and reliable quantification of brain metabolites measured in vivo using 1H magnetic 
resonance spectroscopy (MRS) is a topic of continued interest in the field. Aside from 
differences in the basic approach to quantification, the quantification of metabolite data acquired 
at different sites and on different platforms poses an additional methodological challenge. In this 
study, we analyze spectrally edited J-aminobutyric acid (GABA) MRS data and quantify GABA 
levels relative to an internal tissue water reference. Data from 284 volunteers scanned across 25 
research sites were collected using standard GABA+ editing. Unsuppressed water acquisitions 
from the same volume of interest were acquired for signal referencing. Whole-brain T1-weighted 
structural images were acquired and tissue-segmented to determine gray matter, white matter and 
cerebrospinal fluid voxel tissue fractions. Water-referenced GABA+ measurements were fully 
corrected for tissue-dependent signal relaxation and water visibility effects. The cohort-wide 
coefficient of variation was 17%, which was largely driven by vendor-related differences 
according to a linear mixed-effects analysis. The mean within-site coefficient of variation was 
9%. Vendor differences contributed 53% to the total variance in the data, while the remaining 
variance was attributed to site- (11%) and participant-level (36%) effects. Results from an 
exploratory analysis suggested that the vendor differences were related to the water signal 
acquisition. Discounting the observed vendor-specific effects, water-referenced GABA+ 
measurements exhibit levels of variance similar to creatine-referenced GABA+ measurements. It 
is concluded that quantification using internal tissue water referencing remains a viable and 
reliable method for the in vivo quantification of GABA+ levels. 
 
Keywords: Editing; GABA; MEGA-PRESS; MRS; Multi-site study; Quantification; Tissue 
correction 
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1. Introduction 
In vivo 1H magnetic resonance spectroscopy (MRS) allows noninvasive measurement of 
brain metabolite concentrations, but it does so only in a relative manner. Measurements usually 
rely on an internal reference signal and assumptions about the concentration of the reference 
compound. Common reference signals include the CH3 singlets of the metabolites creatine (Cr) 
and N-acetylaspartate (NAA) and the unsuppressed brain tissue water signal from the same 
volume. Current opinion in the field suggests that there is no reference signal that is optimal in 
all applications, and discussion is ongoing about the relative merits of each (Alger, 2010; Mullins 
et al., 2014). 
The theory and empirical feasibility of the absolute quantification of metabolites as 
measured by MRS is well established (Barker et al., 1993; Christiansen et al., 1993; Danielsen 
and Henriksen, 1994; Ernst et al., 1993; Hennig et al., 1992; Kreis et al., 1993a; Thulborn and 
Ackerman, 1983). Later work has further refined and simplified these approaches, particularly 
with respect to using brain tissue water as an internal concentration reference (Gasparovic et al., 
2018, 2006; Gussew et al., 2012; Knight-Scott et al., 2003). The typical procedure for using 
tissue water as an internal reference is to acquire an unsuppressed water signal using the same 
MRS acquisition protocol as used for the water-suppressed metabolite acquisition in a voxel co-
localized to the volume of interest. With proper assumptions about certain properties of the 
metabolite and water signals and the concentration of water in the various tissue compartments in 
the volume of interest, one may infer absolute metabolite concentrations from the acquired 
metabolite and reference signals. This is supported by the well-characterized properties of MR-
visible water in the brain and its high concentration/large signal. On the other hand, using an 
endogenous metabolite signal, such as Cr, as a reference to derive metabolite ratios avoids the 
need for a separate water acquisition and may reduce error propagation that arises during more 
involved signal scaling procedures, but possibly at the expense of lower signal quality. At 
present, while strong opinions exist on the matter, both metabolite and water referencing have 
advantages and disadvantages (Jansen et al., 2006), and either approach is defensible. Indeed, the 
reliability of each approach has been shown to be similar (Bogner et al., 2010; Saleh et al., 
2016), although in relatively small studies. 
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It is important to note that the concentration and relaxation properties of water, Cr and 
NAA change with disease (Grasso et al., 2002; Huang et al., 2001; Kantarci et al., 2000; Laule et 
al., 2004; Rackayova et al., 2017), aging 0DUMDĔVNDHWDO, 2017; Neeb et al., 2006; Reyngoudt et 
al., 2012) and development .UHLVHWDOE7NiþHWDO. Phantom replacement, 
scanning a phantom of a reference compound of known concentration for comparison to in vivo 
measurements (Buchli and Boesiger, 1993; Duc et al., 1998), can ± with careful attention to 
differences in B0/B1 inhomogeneities, amplifier transmitter/receiver gains and RF coil loading 
factors ± also be used determine in vivo concentrations in absolute units. This method is 
technically challenging, involving additional experiments before or after the scan session, and is 
not commonly used given the difficulties of constructing a phantom with electric conductivity 
similar to human tissue and matching the coil loading factors of the in vivo and phantom samples 
(Jansen et al., 2006). An alternative approach is the ERETIC (electronic reference to access in 
vivo concentrations) method (Barantin et al., 1997; Zoelch et al., 2017), which relies on a 
synthetic RF reference signal. This approach is also challenging and requires specialized 
hardware. For all its limitations, internal concentration referencing remains the most practicable 
and widely used approach in in vivo 1H MRS. 
In addition to the nuances of different quantification methodologies, it is clear that 
systematic differences in acquisition implementation and system hardware will have an impact 
on quantitative outcomes. This makes comparing MRS measurements collected across different 
sites and on different platforms non-trivial. If multi-site and multi-platform MRS studies are to 
be maximally useful, partiFXODUO\LQWKHHUDRI³ELJGDWD´ (Bearden and Thompson, 2017; Miller 
et al., 2016; Van Essen et al., 2013), then the systematic effects on measurement variance must 
be assessed, understood and accounted for. This would then be followed by strategies for 
standardizing data acquisition, data processing and metabolite quantification methods. 
We have recently acquired a large multi-vendor, multi-site dataset, the purpose of which 
is to study the various sources of variance in J-aminobutyric acid (GABA) measurements 
collected by edited MRS. In the first paper describing this dataset (Mikkelsen et al., 2017), 
quantification was performed relative to the total Cr signal in the edit-OFF spectrum. In this 
paper, we quantify GABA relative to brain tissue water and account for individual differences in 
voxel tissue composition. In particular, we seek to determine whether quantification relative to 
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water increases or decreases total variance (compared to Cr referencing) and discuss the impact 
of site- and vendor-related differences in structural image segmentation. 
2. Methods 
A complete description of the acquisition and data processing methodology can be found 
in our original publication (Mikkelsen et al., 2017). Relevant details for this study, especially 
regarding quantification and tissue segmentation, are reported below. 
2.1. Data collection 
Data were acquired at 25 independent research sites, with each site contributing 5±12 
datasets collected from consenting adult volunteers (cohort total: 284). Participants at each site 
were 18±35 years old, approximately 50:50 male/female and had no known neurological or 
psychiatric illnesses. Site-by-site participant demographics are provided in Table 1 in Mikkelsen 
et al. (2017). Scanning was conducted in accordance with ethical standards set by the 
institutional review board (IRB) at each site, including the sharing of anonymized data. 
Anonymized data files were shared securely with and analyzed by the co-authors at the Johns 
Hopkins University School of Medicine with local IRB approval. 
2.2. Data acquisition 
GABA-edited MEGA-PRESS data (Mescher et al., 1998; Rothman et al., 1993) were 
collected at 3T at each site using a standard scan protocol. The MRI vendor breakdown was: 8 
GE; 9 Philips; 8 Siemens. Both standard GABA+-edited and macromolecule-suppressed GABA-
edited acquisitions were performed (Edden et al., 2012b). In this paper, only the water-
referenced GABA+ data are reported, to avoid redundancy with our prior publication (Mikkelsen 
et al., 2017). Complete details of the edited MRS acquisitions, including site-to-site 
idiosyncrasies, can be found in this earlier paper. Briefly, the GABA+ MEGA-PRESS 
acquisition parameters were: TE/TR = 68/2000 ms; 320 averages; 30 u 30 u 30 mm3 medial 
parietal lobe voxel (Fig. 1A); ON/OFF editing pulses = 1.9/7.46 ppm; editing pulse duration = 15 
ms). 
Unsuppressed water signal acquisitions were collected for internal tissue water 
referencing. For the GE and Philips MEGA-PRESS implementations, the water reference was 
automatically acquired as part of the water-suppressed metabolite scan. For GE, the reference 
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was acquired at the end of the suppressed acquisition; 8 or 16 water averages (depending on the 
specific implementation) were acquired. For Philips, the reference was acquired in an interleaved 
manner as the water signal was also used for real-time center frequency correction (Edden et al., 
2016); a single water average was acquired for every 40 water-suppressed acquisitions (8 
averages in total). Acquiring a water reference on the Siemens platform requires running a 
separate scan. For this, the Siemens MEGA-PRESS WIP was used, where the water suppression 
RF pulses were turned off but the water suppression gradients and editing pulses were left on 
³5)2QO\´RSWLRQ; 8 or 16 water averages (depending on acquisition parameters) were 
acquired. The TE/TR of these acquisitions were the same as the water-suppressed acquisitions. 
Whole-brain 3D T1-weighted structural images were acquired for accurate voxel 
placement and partial volume tissue correction. Sequences used were fast spoiled gradient-echo 
imaging (FSPGR; GE) (Low et al., 1993) and magnetization-prepared rapid gradient-echo 
imaging (MPRAGE; Philips/Siemens) (Mugler and Brookeman, 1990) (see Table 1 for 
acquisition parameters). Site-standard structural imaging protocols were used, with less effort to 
standardize acquisitions than the MRS protocols. Imaging data were saved in DICOM (GE and 
some Siemens sites) or NIfTI format (Philips and some Siemens sites). DICOM files were 
converted into NIfTI format for voxel segmentation and tissue segmentation purposes (see 
Section 2.4) using SPM12 (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/). 
2.3. Data processing 
MRS data were processed in Gannet (Edden et al., 2014) using the pipeline described in 
our earlier report (Mikkelsen et al., 2017). Unsuppressed water acquisitions were processed in 
the same manner as the water-suppressed acquisitions and averaged. Briefly, processing steps 
included: frequency-and-phase correction by spectral registration (Near et al., 2015) (water-
suppressed data only); 3-Hz exponential line broadening; zero-filling to yield a nominal spectral 
resolution of 0.061 Hz/point; and fast Fourier transformation into the frequency domain. Quality 
control and quality metrics were conducted and calculated as before. The linewidth of the water 
reference was measured as the full-width at half-maximum (FWHM) of the modeled water signal 
(see Section 2.5). As an independent measure of spectral linewidth, we report NAA FWHM 
linewidth, measured from the Lorentzian-modeled NAA signal in the OFF spectrum. 
2.4. Voxel co-registration and tissue segmentation 
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MRS voxels were co-registered to HDFKYROXQWHHU¶VVWUXFWXUDOimage using the 
GannetCoRegister module in Gannet (Harris et al., 2015), which produces binary voxel masks in 
individual structural space. Structural images were segmented into gray matter (GM), white 
matter (WM) and cerebrospinal fluid (CSF) probabilistic partial volume maps using the unified 
tissue segmentation algorithm in SPM12 (Ashburner and Friston, 2005), executed through the 
GannetSegment module (Harris et al., 2015). Voxel tissue fractions were calculated by 
multiplying the whole-brain partial volume maps by the corresponding binary voxel mask, 
summing over the partial volume estimates in the segmented voxel and then dividing by the 
voxel total. 
2.5. Quantification 
The 3.0 ppm edited GABA signal was modeled as described in our previous publication 
(Mikkelsen et al., 2017). The water spectrum was modeled between 3.8 and 5.6 ppm with a 
Gaussian-Lorentzian function with phase and linear baseline parameters using nonlinear least-
squares fitting. GABA+ measurements were quantified in pseudo-absolute concentration units 
and corrected for partial volume effects (Gasparovic et al., 2006; Harris et al., 2015) based on the 
following equation: ܥୋ ൌ ூృூ౓ ή ு౓ுృ ή ெெ఑ ή ൝σ ஼౓ǡ೔ ୣ୶୮൬ି ೅ಶ౓೅మ౓ǡ೔൰൤ଵିୣ୶୮൬ି ೅ೃ౓೅భ౓ǡ೔൰൨௙೔ృ౉ǡ౓౉ǡి౏ూ೔ ୣ୶୮൬ି೅ಶృ೅మృ൰൤ଵିୣ୶୮൬ି೅ೃృ೅భృ൰൨ ൡ ή ቂ ఓృ౉ାఈఓ౓౉ሺ௙ృ౉ାఈ௙౓౉ሻሺఓృ౉ାఓ౓౉ሻቃ (1) 
where CG is the GABA+ concentration in institutional units (i.u.); IG and IW are the GABA+ and 
water signal integrals, respectively; HW and HG are the number of 1H protons that give rise to the 
water and 3.0 ppm GABA signals (both 2), respectively; MM is a correction factor for the 
contribution of the co-edited macromolecule signal in the GABA+ signal, assumed to be 0.45; 
and N is the editing efficiency, assumed to be 0.5. TEG, TEW, TRG and TRW are the echo and 
relaxation times of the GABA-edited and water acquisitions, respectively. T1W,i is the 
longitudinal relaxation time of water in GM (assumed to be 1331 ms), WM (assumed to be 832 
ms) (Wansapura et al., 1999) or CSF (assumed to be 3817 ms) (Lu et al., 2005); T2W,i is the 
transverse relaxation time of water in GM (assumed to be 110 ms), WM (assumed to be 79.2 ms) 
(Wansapura et al., 1999) or CSF (assumed to be 503 ms) (Piechnik et al., 2009). T1G and T2G are 
the longitudinal and transverse relaxation times of GABA, assumed to be 1310 and 88 ms, 
respectively (Edden et al., 2012a; Puts et al., 2013). CW,i is the concentration of MR-visible water 
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in GM (assumed to be 43.30 mol/kg), WM (assumed to be 36.08 mol/kg) or CSF (assumed to be 
53.84 mol/kg) (Ernst et al., 1993; Gasparovic et al., 2006); fi is the volume fraction of GM, WM 
or CSF in the MRS voxel. D is a correction factor that accounts for the relative differences in the 
intrinsic concentration of GABA in WM and GM (Harris et al., 2015), assumed to be 0.5 
(Mikkelsen et al., 2016); PGM and PWM are the average GM and WM voxel volume fractions 
averaged at the site level, which normalize the D-corrected GABA+ values to the site-mean fGM 
(Harris et al., 2015). 
Fit quality for the water peak model (the fit error) was assessed by normalizing the 
standard deviation (SD) of the model fit residuals to the amplitude of the modeled signal (Edden 
et al., 2014). This metric, the degree to which the measured signal cannot accurately be modeled 
as a Gaussian-Lorentzian, captures eddy current artifacts and some aspects of sub-optimal 
shimming. 
To examine whether systematic effects on the variance of the GABA+ data were 
attributed to the water acquisition, we also quantified water-referenced Cr measurements. The 
3.0 ppm Cr signal in the OFF spectrum was modeled as described in our previous publication. 
The longitudinal and transverse relaxation times of Cr were assumed to be 1350 and 154 ms, 
respectively (Mlynárik et al., 2001); D was assumed to be 0.5 (Doyle et al., 1995; Wang and Li, 
1998). MM and N were not applied. Finally, we examined the degree of association between 
SDUWLFLSDQWV¶ZDWHU-referenced, tissue-corrected GABA+ values and their previously quantified 
GABA+/Cr values as reported in Mikkelsen et al. (2017). It should be noted that these 
measurements are not independent (the GABA+ integral being a common factor) and, therefore, 
a strong correlation was expected. 
2.6. Exploratory analysis 
The results revealed systematically higher water-referenced GABA+ measurements from 
the Siemens sites as compared to the GE and Philips measurements (see Section 3). This level of 
variation was not apparent in the Cr-referenced GABA+ measurements that we previously 
reported (Mikkelsen et al., 2017). To reconcile this, we conducted an unplanned exploratory 
analysis in which the Siemens GABA+ measurements were referenced to a water signal acquired 
by a separate unsuppressed short-TE PRESS acquisition that was collected alongside the MEGA-
PRESS data (data to be reported on in an upcoming publication). This acquisition was acquired 
12 
 
at TE/TR = 35/2000 ms from a voxel in the same location as the MEGA-PRESS acquisition. 
Concentrations were quantified according to Eq. (1) without additional correction for any 
possible amplifier gain differences between the PRESS and MEGA-PRESS acquisitions. 
2.7. Statistical analysis 
Linear mixed-effects models were fit to the water-referenced GABA+ data in R (version 
3.5.1; R Core Team) using the lme4 package (Bates et al., 2015) and maximum likelihood for 
parameter estimation. An unconditional model (Eq. (1) in Mikkelsen et al., 2017) was fit to 
calculate variance partition coefficients (VPCs) to estimate the proportion of total variance 
attributed to vendor-, site- and participant-related effects. Secondary, conditional linear mixed-
effects models (Eq. (5) in Mikkelsen et al., 2017) were also fit to the data to assess the impact of 
NAA linewidth, fGM, age and sex, and to test the association with GABA+/Cr measurements. 
Goodness-of-fit was calculated as a log-likelihood statistic. Significance testing was performed 
using chi-square likelihood ratio tests, which were bootstrapped 2,000 times using parametric 
bootstrapping (Halekoh and Højsgaard, 2014). Effects were tested in the following order: vendor 
and site; NAA linewidth and fGM; age and sex. If an effect was significant, the relevant variable 
was retained in the next model; if not, it was removed. Unconditional linear mixed-effects 
models were also fit to the voxel tissue fractions to test for site and vendor effects. Post-hoc 
pairwise comparisons were corrected for multiple comparisons using the Holm-Bonferroni 
method (Holm, 1979). A p-value less than 0.05 was considered significant. 
3. Results 
Data from seven volunteers were removed from further analysis following quality control 
of the MRS data (largely due to excessive lipid contamination). One further dataset was removed 
because the unusually small water reference signal indicated an acquisition error. Vendor-mean 
GABA+-edited difference spectra are shown in Fig. 1B. 
Fig. 2 shows the GABA+ values arranged by site and by vendor. Mean r 1 SD GABA+ 
measurements were 2.45 r 0.30 i.u. for GE, 2.46 r 0.27 i.u. for Philips and 3.15 r 0.36 i.u. for 
Siemens. Siemens values were on average 29% higher than the GE (pholm < 0.001) and Philips 
(pholm < 0.001) values. The cohort-wide average was 2.67 r 0.45 i.u. Coefficients of variation 
(CVs) were 12.4%, 10.8% and 11.3% for GE, Philips and Siemens, and 16.7% across all sites 
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and vendors. The mean within-site CV was 9.4%. GM, WM and CSF fractions are displayed in 
Fig. 3. Across the cohort, the average (and CV of) fGM, fWM and fCSF was 0.59 r 0.04 (6.9%), 0.28 
r 0.04 (14.0%) and 0.13 r 0.05 (36.7%), respectively. Values of GABA+, fGM, fWM and fCSF for 
each site are listed in Table 2. 
Water fit errors, water linewidths and Cr measurements are displayed in Fig. 4, with site- 
and vendor-averaged values given in Table 2. On average, fit errors were small, and lower for 
Siemens (0.38%) compared to GE (0.56%) and Philips (0.56%). Water linewidths were similar 
across the vendors, with Philips (9.01 r 0.62 Hz) and Siemens (9.04 r 0.57 Hz) showing slightly 
smaller linewidths compared to GE (9.37 r 0.84 Hz). Average water-referenced Cr 
measurements were 10.78 r 0.90 i.u. for GE, 11.95 r 1.17 i.u. for Philips and 14.73 r 1.19 i.u. 
for Siemens. 
3.1. Linear mixed-effects analyses 
The unconditional linear mixed-effects model showed that vendor and site effects 
contributed significantly to the total amount of variance in the data: F2(1) = 27.62, pboot < 0.001 
and F2(1) = 30.40, pboot < 0.001, respectively. Based on the calculated VPCs, 52.9% of the 
variance was accounted for by vendor-level differences, while 11.2% was accounted for by site-
level differences. The remaining proportion of variance (35.9%) was attributed to individual 
differences in participants. 
The voxel tissue fractions exhibited significant site-related effects for fGM [F2(1) = 56.33, 
pboot = 0.001], fWM [F2(1) = 46.77, pboot < 0.001] and fCSF [F2(1) = 47.22, pboot < 0.001], but only 
fWM showed an additional vendor-related effect [F2(1) = 4.08, pboot = 0.01]. Corresponding VPCs 
for fGM were: vendor = negligible; site = 31.4%; participant = 68.6%. For fWM these were: vendor 
= 12.8%; site = 24.9%; participant = 62.3%. For fCSF these were: vendor = 1.8%; site = 28.5%; 
participant = 69.7%. Pairwise comparisons showed that, at the vendor level, the Siemens fWM 
values were significantly higher than the GE (pholm = 0.001) and Philips (pholm = 0.003) values. 
Based on the conditional linear mixed-effects analyses, GABA+ levels were not 
significantly impacted by the effects of NAA linewidth [F2(5) = 4.37, pboot = 0.50]. GABA+ 
levels did, however, show a relationship with fGM [F2(5) = 10.14, pboot = 0.02]. To examine the 
effectiveness of the metabolite tissue correction (i.e., the D-correction term in Eq. (1)), the by-
site and cohort-wide effects of fGM on the tissue-water-corrected GABA+ data before and after D-
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correction are displayed in Fig. 5. The pre-corrected data show a strong association with fGM (R2 
= 0.18) that is reduced after D-correction (R2 = 0.08), a 50% decrease in the variance shared with 
fGM. There were no significant effects of age [F2(5) = 1.77, pboot = 0.88] or sex [F2(5) = 0.88, pboot 
= 0.97] on the data. As shown in Fig. 6, the water-referenced GABA+ measurements were 
strongly related to the GABA+/Cr measurements, as expected [F2(5) = 253.86, pboot < 0.001]. 
3.2. Exploratory analysis 
Using the Siemens short-TE water reference brought down the Siemens GABA+ values 
to an average of 2.68 r 0.32 i.u. (a 15% reduction), reducing the discrepancy with the other 
vendors to 9% (boxplots plotted in Fig. S1). Corresponding VPCs were: vendor = 10.9%; site = 
24.4%; participant = 64.6%, with vendor and site effects remaining significant: F2(1) = 3.43, pboot 
= 0.02 and F2(1) = 33.01, pboot < 0.001, respectively. The short-TE-referenced Siemens Cr 
measurements were also reduced on average (by 14%, to 12.60 r 1.49 i.u.) compared to the 
initial analysis, again closer to the GE and Philips Cr measurements (Fig. S2). 
4. Discussion 
In this second paper on a large multi-vendor, multi-site GABA-edited MRS dataset, we 
have shown that water-referenced GABA+ measurements, including tissue correction based on 
variously acquired T1-weighted structural images, can be applied across sites and vendors with 
relatively low levels of variance. Water-referenced quantification shows very similar levels of 
performance to Cr referencing, as reported previously (Mikkelsen et al., 2017), with the notable 
exception of an additional vendor-related effect. 
One objective of this study was to compare quantitative outcomes of water and Cr 
referencing. Within site, water- and Cr-referenced GABA+ measurements show very similar 
levels of variance (mean within-site CV: 9.4% vs. 9.5%, respectively). Levels of site-related 
variance are also similar (mean within-vendor CV: 11.5% vs. 11.3%, respectively). The major 
difference between the water- and Cr-referenced results was the systematic effect of vendor in 
the water-referenced data.  
It is not clear why the GABA+ values from the Siemens data were substantially larger 
than the estimates from the other two vendors. This substantial vendor-related difference was not 
observed in the Cr-referenced data reported previously (Mikkelsen et al., 2017). Higher GABA+ 
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values indicate a lower-than-expected water signal. Referencing to a short-TE PRESS water 
acquisition attenuated the discrepancy somewhat, suggesting that the Siemens MEGA-PRESS 
WIP water reference signal is most likely at issue. It is notable that the water fit errors were 
somewhat lower in the Siemens data, suggesting that the water signal is closer to a Gaussian-
Lorentzian lineshape than the other vendors. It is worth mention that the data analyzed undergo 
differing degrees of preprocessing (e.g., downsampling from the analog-to-digital converter 
sampling rate to the specified acquisition rate), with potentially different dynamic range 
performance ± the water reference signal is ~10,000 times larger than the GABA signal and 
acquired with the same receiver gains. At this stage, it has not been possible to isolate the cause 
of this result. 
Aside from this vendor effect, it was clear that the variation in the water-referenced 
GABA+ measurements was quite similar to the GABA+/Cr measurements This suggests that the 
reliability of these two referencing strategies is comparable, consistent with previous (smaller) 
studies (Bogner et al., 2010; Saleh et al., 2016). This is perhaps surprising as several additional 
corrections were performed to obtain the water-referenced values, which introduces more 
sources of error into the quantification. 
Quantification in this study used a best-practice approach, whereby the water reference 
signal was corrected for partial volume effects and relaxation. It has been shown that failing to 
account for these effects will lead to quantification errors (Gasparovic et al., 2018). These errors 
can be particularly pronounced at longer TEs (Gasparovic et al., 2006) or when there is large 
variability in tissue compartment fractions across cohorts (Harris et al., 2015; Mato Abad et al., 
2014; Mikkelsen et al., 2016; Tal et al., 2012). The relatively low level of variance in the present 
dataset suggests that incorporating image-based voxel segmentation into the quantification 
routine did not add significant variance into the data. 
Nonetheless, subtle differences in quantification and tissue correction methodologies can 
have important consequences on reported results. For instance, the linear relationship between 
GABA+ levels and age, seen when applying a simple CSF tissue correction, is not observed 
when applying fuller D-correction to remove the dependency of GABA+ levels on tissue 
composition (Maes et al., 2018; Porges et al., 2017). Additionally, the units of measurement of 
water-referenced metabolite concentrations, and the information content of the values, will 
depend on the quantification approach used. Metabolite concentrations have been reported in 
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molar, molal and institutional units (Gasparovic et al., 2018; Jansen et al., 2006; Knight-Scott et 
al., 2003; Kreis et al., 1993a). Interpretation of stated concentrations, and particularly 
comparisons across studies, can be challenging. In this study, we report our measurements in 
institutional units. This was in part because the D-correction applied to the tissue-water-corrected 
measurements effectively normalized the site-level values to the amount of GABA+ that 
theoretically would have been observed would the signal have been detected in a voxel 
composed of a fraction of GM and WM equal to the average of fractional GM and WM of the 
site-specific cohort. This does not prevent the values from being compared across studies, 
however; it simply demonstrates that the values presented here may differ from those presented 
elsewhere as a result of the quantification approach that was used. 
Not every possible source of variance was captured in the statistical analysis. One source 
of error, for instance, was the diversity of the T1-weighted structural imaging protocols. 
Differences in imaging preparation and readout will result in heterogeneity in T1-weighted 
contrast and image signal-to-noise ratio, which might in turn lead to variable segmentation 
outcomes. In our data, there were small but significant site-to-site differences in voxel 
segmentation. There is an extensive literature on the successes and limitations of image 
segmentation (Clark et al., 2006; Eggert et al., 2012; Klauschen et al., 2009), and while 
segmentation algorithms aim to be robust against the effects of imaging parameters, 
segmentation remains a challenging undertaking. At this stage, it is unclear to what degree error 
from segmentation inaccuracies propagates into metabolite quantification. The substantial tissue 
differences in water T2, particularly given the medium TE of the water acquisitions (68 ms), and 
in GABA and MR-visible water concentrations, suggest that accurate segmentation is important 
for reproducible water-referenced quantification. 
In summary, we quantified GABA+ levels using brain tissue water as an internal 
concentration reference across 25 sites and observed low levels of within-site variance. This 
level of variability is similar to that seen for GABA+ measurements quantified relative to Cr. 
Thus, the choice of reference signal for MRS quantification is not determined by inherent 
differences in performance, but rather by study-specific expectations of reference signal stability 
(e.g., between-group differences in clinical populations). Indeed, given the concern that observed 
effects might be driven by changes in the reference signal, it is often helpful to quantify both 
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water- and metabolite-referenced measurements. That said, we conclude that water-referenced 
measurements of GABA+ are sufficiently reliable to be applied in multi-site studies. 
Appendix 
The data presented in this work has been made available on the NITRC portal in WKH³%LJ
*$%$´SURMHFWUHSRVLWRU\https://www.nitrc.org/projects/biggaba/) and is distributed freely 
under a non-commercial Creative Commons license. Community members are encouraged to 
make use of this resource for developing and optimizing new MRS methods. This data resource 
can also serve as a normative dataset against which clinical data may be compared or for quality 
assurance purposes. 
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Fig. 1. (A) Representative MRS voxel placement on a T1-weighted structural image and 
probabilistic partial volume voxel maps following tissue segmentation for one participant. 
Corresponding tissue fractions of gray matter (GM), white matter (WM) and cerebrospinal fluid 
(CSF) are shown. (B) Vendor-mean GABA+-edited difference spectra. The gray patches 
represent r1 standard deviation. The associated sample sizes are shown in parentheses. 
 
Fig. 2. Water-referenced GABA+ measurements fully corrected for partial volume effects, 
displayed by site and by vendor. The boxes shaded with lighter colors represent ±1 standard 
deviation and the darker boxes represent the 95% confidence interval. The solid white lines 
denote the mean, while the dashed white lines denote the median. Sites are colored by vendor 
(GE sites in green, Philips sites in orange, Siemens sites in blue). 
 
Fig. 3. Gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) voxel tissue 
fractions, displayed by site and by vendor. GM = gray fill; WM = white fill; CSF = black fill. 
The red lines denote the mean. Sites are colored by vendor (GE sites with a green background, 
Philips sites with an orange background, Siemens sites with a blue background). 
 
Fig. 4. Quality metrics and water-referenced Cr measurements, displayed by site and by vendor. 
(A) water fit error; (B) water linewidth; (C) Cr measurements fully corrected for partial volume 
effects. The boxes shaded with lighter colors represent ±1 standard deviation and the darker 
boxes represent the 95% confidence interval. The solid white lines denote the mean, while the 
dashed white lines denote the median. Sites are colored by vendor (GE sites in green, Philips 
sites in orange, Siemens sites in blue). 
 
Fig. 5. Scatterplots displaying tissue-water-corrected GABA+ measurements as a function of 
gray matter voxel tissue fraction (fGM) (A) before and (B) after D-correction to account for 
intrinsic differences in gray and white matter GABA. Individual measurements are color-coded 
by vendor (GE in green, Philips in orange, Siemens in blue). The black regression lines show the 
relationship between fGM and water-referenced GABA+ over the entire dataset. Additional color-
coded regression lines are shown for each site. R2 values (i.e., effect sizes) are also displayed. 
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Fig. 6. Scatterplot illustrating the relationship between water-referenced GABA+ measurements 
and GABA+/Cr ratios. Individual measurements are color-coded by vendor (GE in green, Philips 
in orange, Siemens in blue). The black regression line shows the relationship between 
GABA+/Cr and water-referenced GABA+ over the entire dataset. Additional color-coded 
regression lines are shown for each site. The R2 value (i.e., the effect size) is also displayed. 
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Table 1. Hardware and acquisition parameters used to collect 3D T1-weighted structural images at each site. 
Site ID Tx/Rx hardware Voxel resolution (mm3) TE/TI/TR (ms) Scan time (m:ss) Flip angle (deg) Slices FOV (mm2) Matrix size Acceleration (factor) 
G1 Body coil/32-ch head coil 0.94 u 0.94 u 1 2.68/600/7.42 4:07 10 226 256 u 256 256 u 256 ASSET (2) 
G2 Body coil/8-ch head coil 0.9 u 0.9 u 1 2.73/650/6.24 2:54 8 180 256 u 256 256 u 256 ARC (2) 
G3 Body coil/32-ch head coil 1 u 1 u 1 2.6/500/6.4 4:37 11 180 256 u 256 256 u 256 ASSET (2) 
G4 Body coil/8-ch head coil 1 u 1 u 1 2.98/450/6.89 9:35 12 192 256 u 256 256 u 256 None 
G5 Body coil/32-ch head coil 0.5 u 0.5 u 0.8 2.1/450/7.09 5:39 12 232 256 u 256 512 u 512 None 
G6 Body coil/8-ch head coil 1 u 1 u 2 2.66/400/6.24 6:22 12 124 240 u 240 240 u 240 None 
G7 Body coil/8-ch head coil 1 u 1 u 1 3.2/450/8.2 4:30 12 176 256 u 256 256 u 256 ARC (2) 
G8 Body coil/8-ch head coil 1 u 1 u 1 4.17/450/10.19 5:27 12 180 256 u 256 256 u 256 ARC (2) 
P1 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P2 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P3 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P4 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P5 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 170 256 u 256 256 u 256 SENSE (2) 
P6 Body coil/8-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P7 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P8 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 204 256 u 256 256 u 256 SENSE (2) 
P9 Body coil/32-ch head coil 1 u 1 u 1 3.1/865/6.9 7:10 8 176 256 u 256 256 u 256 SENSE (2) 
S1 Body coil/32-ch head coil 1 u 1 u 1 2.52/900/1900 4:18 9 176 250 u 250 256 u 256 GRAPPA (2) 
S2 Body coil/32-ch head coil 1 u 1 u 1 2.85/1050/1900 5:43 9 176 256 u 256 256 u 256 GRAPPA (2) 
S3 Body coil/20-ch head/neck coil 1 u 1 u 1 1.77/900/1900 4:05 8 160 256 u 256 128 u 256 GRAPPA (2) 
S4 Body coil/64-ch head coil 1 u 1 u 1 4.11/1000/2000 3:36 12 160 256 u 256 256 u 256 GRAPPA (2) 
S5 Body coil/12-ch head coil 1 u 1 u 1 4.6/900/1950 4:01 9 176 192 u 256 192 u 256 GRAPPA (2) 
S6 Body coil/32-ch head coil 1 u 1 u 1 2.26/900/1900 4:26 9 192 256 u 256 256 u 256 GRAPPA (2) 
S7 Body coil/32-ch head coil 1 u 1 u 1 3.03/900/2300 5:21 9 192 256 u 256 256 u 256 GRAPPA (2) 
S8 Body coil/64-ch head coil 1 u 1 u 1 3.02/900/1900 4:01 9 160 256 u 256 256 u 256 GRAPPA (2) 
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Table 2. Quantification, tissue fractions and water data quality metrics, displayed by site and by vendor (shown as mean r 1 standard deviation). 
Site ID GABA+ (i.u.) Cr (i.u.) fGM fWM fCSF Water fit error (%) Water linewidth (Hz) 
G1 2.47 r 0.13 11.69 r 1.00 0.60 r 0.05 0.26 r 0.04 0.14 r 0.03 0.95 r 0.09 9.43 r 0.48 
G2 2.72 r 0.19 11.19 r 0.61 0.56 r 0.02 0.29 r 0.03 0.15 r 0.03 0.57 r 0.11 9.98 r 0.73 
G3 2.15 r 0.19 10.16 r 0.69 0.60 r 0.03 0.29 r 0.02 0.11 r 0.03 0.43 r 0.09 9.46 r 0.76 
G4 2.45 r 0.28 10.54 r 0.52 0.60 r 0.03 0.28 r 0.02 0.12 r 0.04 0.42 r 0.06 9.34 r 0.40 
G5 2.20 r 0.16 10.33 r 0.41 0.65 r 0.05 0.26 r 0.01 0.09 r 0.04 0.55 r 0.11 9.79 r 0.63 
G6 2.36 r 0.42 9.65 r 0.76 0.54 r 0.04 0.32 r 0.02 0.15 r 0.04 0.65 r 0.07 9.80 r 0.92 
G7 2.56 r 0.28 11.28 r 0.55 0.57 r 0.05 0.23 r 0.02 0.19 r 0.06 0.47 r 0.11 8.72 r 0.88 
G8 2.56 r 0.28 11.10 r 0.49 0.57 r 0.03 0.23 r 0.05 0.21 r 0.05 0.41 r 0.09 8.40 r 0.42 
All GE 2.45 r 0.30 10.78 r 0.90 0.58 r 0.05 0.27 r 0.04 0.15 r 0.05 0.56 r 0.19 9.37 r 0.84 
P1 2.44 r 0.28 11.46 r 0.78 0.60 r 0.03 0.27 r 0.04 0.13 r 0.04 0.47 r 0.07 8.78 r 0.53 
P2 2.34 r 0.19 11.55 r 0.71 0.56 r 0.03 0.29 r 0.02 0.15 r 0.04 0.43 r 0.07 8.74 r 0.40 
P3 2.42 r 0.18 11.24 r 0.94 0.58 r 0.02 0.29 r 0.03 0.13 r 0.03 0.84 r 0.11 9.02 r 0.43 
P4 2.58 r 0.42 11.86 r 0.56 0.59 r 0.02 0.26 r 0.02 0.15 r 0.03 0..32 r 0.06 8.78 r 0.38 
P5 2.24 r 0.18 11.32 r 0.75 0.63 r 0.03 0.27 r 0.02 0.11 r 0.03 0.75 r 0.08 9.06 r 0.24 
P6 2.64 r 0.20 13.19 r 1.19 0.57 r 0.02 0.25 r 0.03 0.18 r 0.05 0.67 r 0.17 8.71 r 0.53 
P7 2.30 r 0.16 11.88 r 0.47 0.63 r 0.03 0.27 r 0.03 0.10 r 0.03 0.69 r 0.11 10.21 r 0.62 
P8 2.66 r 0.23 13.84 r 0.54 0.61 r 0.04 0.28 r 0.03 0.11 r 0.04 0.40 r 0.04 9.03 r 0.29 
P9 2.45 r 0.17 11.13 r 0.93 0.59 r 0.02 0.28 r 0.04 0.12 r 0.03 0.50 r 0.06 8.77 r 0.31 
All Philips 2.46 r 0.27 11.95 r 1.17 0.59 r 0.04 0.27 r 0.03 0.13 r 0.04 0.56 r 0.19 9.01 r 0.62 
S1 3.06 r 0.17 14.76 r 0.84 0.57 r 0.03 0.30 r 0.03 0.12 r 0.05 0.39 r 0.08 9.40 r 0.72 
S2 3.47 r 0.29 17.24 r 0.28 0.55 r 0.02 0.33 r 0.02  0.12 r 0.03 0.38 r 0.03 9.22 r 0.36 
S3 2.83 r 0.30 14.86 r 0.98 0.56 r 0.03 0.33 r 0.04 0.11 r 0.04 0.30 r 0.06 8.63 r 0.39 
S4 3.16 r 0.33 14.05 r 0.57 0.61 r 0.03 0.29 r 0.02 0.10 r 0.04 0.33 r 0.05 8.81 r 0.31 
S5 3.28 r 0.53 14.45 r 1.60 0.59 r 0.05 0.31 r 0.04 0.10 r 0.07 0.42 r 0.11 9.45 r 0.92 
S6 3.01 r 0.11 14.57 r 0.42 0.59 r 0.04 0.30 r 0.03 0.11 r 0.03 0.44 r 0.08 9.12 r 0.28 
S7 3.27 r 0.25 13.88 r 0.96 0.58 r 0.03 0.28 r 0.03 0.14 r 0.04 0.46 r 0.08 8.98 r 0.39 
S8 3.31 r 0.38 15.52 r 0.61 0.58 r 0.03 0.29 r 0.03 0.13 r 0.02 0.33 r 0.07 8.84 r 0.36 
All Siemens 3.15 r 0.37 14.73 r 1.19 0.58 r 0.04 0.30 r 0.04 0.12 r 0.04 0.38 r 0.10 9.04 r 0.57 
Overall 2.67 r 0.45 12.42 r 1.94 0.59 r 0.04 0.28 r 0.04 0.13 r 0.05 0.51 r 0.19 9.14 r 0.70 
 
